BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7906451)

  • 1. Altered expression of beta-2-microglobulin in basaloid proliferations overlying dermatofibromas.
    Rossen K; Hou-Jensen K; Werdelin O
    Acta Derm Venereol; 1993 Dec; 73(6):419-21. PubMed ID: 7906451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas.
    Haerslev T; Rossen K; Hou-Jensen K; Jacobsen GK
    Acta Derm Venereol; 1995 May; 75(3):187-9. PubMed ID: 7653177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas.
    Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
    Br J Dermatol; 1997 Jan; 136(1):30-4. PubMed ID: 9039291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 overexpression in basaloid proliferations overlying dermatofibromas and basal cell carcinomas.
    Rossen K; Haerslev T; Hou-Jensen K; Jacobsen GK
    APMIS; 1997 Jan; 105(1):35-40. PubMed ID: 9063499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Basal cell carcinoma overlying a dermatofibroma].
    Córdoba S; Hernández A; Romero A; Arias D; Castaño E; García-Donoso C; Borbujo JM
    Actas Dermosifiliogr; 2005 Nov; 96(9):612-5. PubMed ID: 16476308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cytokeratin 20 staining of Merkel cells helps differentiate basaloid proliferations overlying dermatofibromas from basal cell carcinoma.
    Mahmoodi M; Asad H; Salim S; Kantor G; Minimo C
    J Cutan Pathol; 2005 Aug; 32(7):491-5. PubMed ID: 16008693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal basaloid proliferation in cutaneous myxomas.
    Mehregan DR; Thomas L; Thomas JE
    J Cutan Pathol; 2003 Sep; 30(8):499-503. PubMed ID: 12950501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation and differentiation of the keratinocytes in hyperplastic epidermis overlying dermatofibroma: immunohistochemical characterization.
    Han KH; Huh CH; Cho KH
    Am J Dermatopathol; 2001 Apr; 23(2):90-8. PubMed ID: 11285402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal cell carcinomas and basal cell carcinoma-like changes overlying dermatofibromas.
    Goette DK; Helwig EB
    Arch Dermatol; 1975 May; 111(5):589-92. PubMed ID: 165782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal basaloid cell hyperplasia overlying dermatofibromas.
    Lindboe CF; Løvdal L
    Am J Dermatopathol; 2011 Feb; 33(1):52-5. PubMed ID: 21178581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basaloid/follicular hyperplasia overlying connective tissue/mesenchymal hamartomas simulating basal cell carcinomas.
    Stashower ME; Smith K; Corbett D; Skelton HG
    J Am Acad Dermatol; 2001 Dec; 45(6):886-91. PubMed ID: 11712034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An absence of human leukocyte antigen-DR and a decreased expression of beta 2-microglobulin on tumor cells of basal cell carcinoma: no influence on the peritumoral immune infiltrate.
    Habets JM; Tank B; Vuzevski VD; Stolz E; van Joost T
    J Am Acad Dermatol; 1989 Jan; 20(1):47-52. PubMed ID: 2521495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cell carcinoma overlying a dermatofibroma: a revisited controversy.
    Rosmaninho A; Farrajota P; Peixoto C; Amorim I; Selores M
    Eur J Dermatol; 2011; 21(1):137-8. PubMed ID: 21233074
    [No Abstract]   [Full Text] [Related]  

  • 14. Follicular basal cell hyperplasia overlying dermatofibroma.
    Cheng L; Amini SB; Tarif Zaim M
    Am J Surg Pathol; 1997 Jun; 21(6):711-8. PubMed ID: 9199650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatofibroma: upregulation of syndecan-1 expression in mesenchymal tissue.
    Sellheyer K; Smoller BR
    Am J Dermatopathol; 2003 Oct; 25(5):392-8. PubMed ID: 14501288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The man behind the eponym: Hans Biberstein and follicular hyperplasia overlying dermatofibroma.
    Hamel J; Burgdorf WH; Bräuninger W
    Am J Dermatopathol; 2009 Oct; 31(7):710-4. PubMed ID: 19633531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistologic study of cellular populations of histiocytofibromas ("dermatofibromas").
    Kanitakis J; Schmitt D; Thivolet J
    J Cutan Pathol; 1984 Apr; 11(2):88-94. PubMed ID: 6330187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary sclerotic fibroma of the skin: a sclerotic dermatofibroma?
    Pujol RM; de Castro F; Schroeter AL; Su WP
    Am J Dermatopathol; 1996 Dec; 18(6):620-4. PubMed ID: 8989937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lichenoid, erosive and ulcerated dermatofibromas. Three additional clinico-pathologic variants.
    Sánchez Yus E; Soria L; de Eusebio E; Requena L
    J Cutan Pathol; 2000 Mar; 27(3):112-7. PubMed ID: 10728811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sebaceous hyperplasia overlying a dermatofibroma.
    Davis TT; Calilao G; Fretzin D
    Am J Dermatopathol; 2006 Apr; 28(2):155-7. PubMed ID: 16625080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.